Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2011
03/17/2011US20110065706 Therapeutic Agents 812
03/17/2011US20110065703 Novel agents of calcium ion channel modulators
03/17/2011US20110065696 Imidazoyl pyridine compounds and salts thereof
03/17/2011US20110065694 Histamine H3 Inverse Agonists and Antagonists and Methods of Use Thereof
03/17/2011US20110065679 Substituted Porphyrins
03/17/2011US20110064892 Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base
03/17/2011US20110064694 Anti-hepatitis c activity of meso-tetrakis-porphyrin analogues
03/17/2011US20110062429 Compound for organic electroluminescent device and organic electroluminescent device
03/17/2011CA2773854A1 Pharmaceutically useful heterocycle-substituted lactams
03/17/2011CA2773848A1 Pi3 kinase inhibitors and uses thereof
03/17/2011CA2773661A1 Ether derivatives of bicyclic heteroaryls
03/17/2011CA2773182A1 Inhibitors of jak
03/17/2011CA2772525A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
03/17/2011CA2772522A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
03/17/2011CA2770712A1 Heterocyclic compounds as janus kinase inhibitors
03/16/2011EP2295550A2 Crystal structures of GSK-3beta protein and protein complexes and their use.
03/16/2011EP2295442A2 Inhibitors of interleukin-1beta converting enzyme
03/16/2011EP2295438A1 Process for producing hydroxyalkyltriethylenediamine compound, and catalyst composition for the production of polyurethane resin using the hydroxyalkyltriethylenediamine compound
03/16/2011EP2295437A1 Diazabicyclic central nervous system active agents
03/16/2011EP2295436A1 2-Phenyl-subsitituted Imidazotriazinones as Phosphodiesterase V inhibitors
03/16/2011EP2295435A1 Substituted porphyrins and their therapeutic use
03/16/2011EP2294071A1 PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS
03/16/2011EP2294070A1 New phenanthrylphenol linked pyrrolo[2,l-c][l,4]benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof
03/16/2011EP2294066A1 Benzoimidazoles as prolyl hydroxylase inhibitors
03/16/2011EP2294051A1 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
03/16/2011EP2057165B1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
03/16/2011EP1940846B1 Pyrimidin-4-yl-3,4-dihydro-2h-pyrrolo[1,2a]pyrazin-1-one compounds
03/16/2011CN101986782A Substituted heteroarylamide diazepinopyrimidone derivatives
03/16/2011CN101560212B Preparation for 1,2,4-triazolo[1,5-a]pyrimidine-2-ethyl thioether disubstituted derivative and application thereof
03/15/2011US7906662 Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
03/15/2011US7906649 Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
03/15/2011US7906521 Quinazoline potassium channel inhibitors
03/15/2011US7906512 3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases
03/15/2011US7906499 Polycarboxylated porphyrins and use thereof in treatment of metal toxicities
03/15/2011US7906235 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
03/15/2011US7906039 Fluorescent diketopyrrolopyrroles
03/15/2011CA2397366C Methanocarba cycloalkyl nucleoside analogues
03/15/2011CA2379575C Pharmaceutically active sulfonamide derivatives
03/15/2011CA2315117C Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission
03/10/2011WO2011029027A1 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS
03/10/2011WO2011028685A1 Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
03/10/2011WO2011028610A1 Visible/nir photodetectors
03/10/2011WO2011028580A1 Novel forms of a multicyclic compound
03/10/2011WO2011027249A2 Benzimidazole derivatives
03/10/2011WO2011026579A1 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
03/10/2011WO2010118367A3 Antiviral pyrimidines
03/10/2011WO2010111718A3 Antiviral compounds and methods of use thereof
03/10/2011US20110060097 Dihalogen Indolocarbazole Monomers and Poly (Indolocarbazoles)
03/10/2011US20110060024 Modulators of ATP-Binding Cassette Transporters
03/10/2011US20110059996 Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy
03/10/2011US20110059993 1-(1-(2-Ethoxyethyl)-3-Ethyl-7-(4-Methylpyridin-2-Ylamino)-1H-Pyrazolo[4,3-D]Pyrimidin-5-YL) Piperidine-4-Carboxylic Acid And Salts Thereof
03/10/2011US20110059975 Non-nucleoside reverse transcriptase inhibitors
03/10/2011US20110059959 Novel multicyclic compounds and the use thereof
03/10/2011US20110059951 HETEROCYCLIC DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS
03/10/2011US20110059941 2-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulators
03/10/2011US20110059934 Compounds and compositions useful for the treatment of parasitic diseases
03/10/2011US20110059929 SUBSTITUTED BICYCLIC PIPERIDINYL-AND PIPERAZINYL- SULFONAMIDES USEFUL TO INHIBIT 11beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1
03/10/2011US20110059118 Inhibitors of jak
03/10/2011US20110059018 Covalently binding imaging probes
03/10/2011US20110057175 Organic light emitting device
03/10/2011CA2773038A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
03/10/2011CA2772790A1 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
03/10/2011CA2772328A1 Novel forms of a multicyclic compound
03/10/2011CA2772194A1 Benzimidazole derivatives
03/10/2011CA2771822A1 Bruton's tyrosine kinase inhibitors
03/10/2011CA2771352A1 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
03/09/2011EP2293650A1 Dipyrrolo[a,h]pyrenes for organic light-emitting devices
03/09/2011EP2292623A1 Acylated phthalocyanines
03/09/2011EP2292622A1 New crystalline form of a triazolo(4,5-d)pyrimidine compound
03/09/2011EP2292621A1 Vasopressin v1a antagonists
03/09/2011EP2292620A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prohylaxis and treatment of disorders related thereto
03/09/2011EP2292618A1 Organic light emitting device containing polycyclic heteroaryl compounds
03/09/2011EP2292604A2 Condensed-cyclic compound and organic light emitting diode having organic layer including the same
03/09/2011EP2292601A1 Phenanthro[2,3-b]pyrroles and Phenanthro[3,2-b]pyrroles for organic light-emitting devices
03/09/2011EP2292591A2 Process for the preparation of cyclopropyl derivatives
03/09/2011EP2292582A2 2-substituted 1-(3,4-difluorophenyl)cyclopropane derivatives
03/09/2011EP2292232A1 Beta-amino tetrahydroimidazo(1,2-A)pyrazines and tetrahydrotriazolo(4,3-A)pyrazines for use in the treatment of diabetes type II
03/09/2011EP2291379A1 Substituted quinazolines
03/09/2011EP2291378A2 N- and o-substituted 4-ý2-(diphenylmethoxy)-ethyl¨-1-ý(phenyl)methyl¨piperidine analogs and methods of treating cns disorders therewith
03/09/2011EP2291377A1 Imidazopyrimidinones and uses thereof
03/09/2011EP2079747B1 Heterocyclic compounds useful as anabolic agents for livestock animals
03/09/2011EP1838712B1 Pyrazolopyrimidine compounds as antitumor agents
03/09/2011EP1836206B1 Azolopyrimidine-based inhibitors of dipeptidyl peptidase iv and methods
03/09/2011EP1753765B1 Immuno inhibitory heterocyclic compounds
03/09/2011EP1641795B1 Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals
03/09/2011CN101133057B Triazolophthalazines
03/08/2011US7902376 Process for preparing chiral dipeptidyl peptidase-IV inhibitor intermediates
03/08/2011US7902371 (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
03/08/2011US7902366 NK1 antagonists
03/08/2011US7902239 Diaminotriazoles useful as inhibitors of protein kinases
03/08/2011US7902204 2-(4-Benzoyl-piperazin-1-yl)-3-(4-chloro-5H-pyrrolo[3,2-d]pyrimidin-7-yl)-3-oxo-propionitrile; HIV and AIDS
03/08/2011US7902196 Synthesis of avrainvillamide, strephacidin B, and analogues thereof
03/08/2011US7902102 Pentasil-structuer zeolithic material the production and use thereof
03/08/2011US7901795 OLEDs doped with phosphorescent compounds
03/08/2011CA2634381C Carbonylamino pyrrolopyrazoles, potent kinase inhibitors
03/08/2011CA2488202C 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
03/08/2011CA2446756C Thiazole compounds useful as inhibitors of protein kinase
03/03/2011WO2011026024A2 Imidazo [4,5-d] pyridazine compounds for treating viral infections
03/03/2011WO2011025951A1 Raf inhibitor compounds and methods of use thereof
03/03/2011WO2011025947A1 Raf inhibitor compounds and methods of use thereof